BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/3/2024 10:19:42 AM | Browse: 57 | Download: 0
Category |
Hematology |
Manuscript Type |
Review |
Article Title |
New frontiers in sickle cell disease: The role of antiviral therapies and emerging drugs in managing viral infections
|
Manuscript Source |
Invited Manuscript |
All Author List |
Tarun Sahu, Arunita Tushar Jagzape, Meenakshi Sinha, Ramanjan Sinha and Henu Kumar Verma |
Funding Agency and Grant Number |
|
Corresponding Author |
Henu Kumar Verma, PhD, Department of Lung Health and Immunity, Helmholtz Zentrum Munich, Ingolstädter Landstraße 1, Munich 85764, Bayren, Germany. henu.verma@yahoo.com |
Key Words |
Sickle cell disease; Viral Infection; Virus; Antiviral; Therapeutics |
Core Tip |
Sickle cell disease patients are highly susceptible to viral infections due to their immune compromised state. This review highlights the complications associated with viral infections, its treatment plans, and the role of vaccinations in improving results in these patients. Future research is essential to optimize antiviral approaches in this vulnerable population. |
Citation |
Sahu T, Jagzape AT, Sinha M, Sinha R, Verma HK. New frontiers in sickle cell disease: The role of antiviral therapies and emerging drugs in managing viral infections. World J Virol 2024; In press |
 |
Received |
|
2024-09-25 08:27 |
 |
Peer-Review Started |
|
2024-09-23 13:56 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-11-08 05:39 |
 |
Revised |
|
2024-11-14 13:00 |
 |
Second Decision |
|
2024-12-03 03:04 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-12-03 10:19 |
 |
Articles in Press |
|
2024-12-03 10:19 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-01-02 02:28 |
ISSN |
2220-3249 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345